Searched for
OSTEOARTHRITIS NEW TREATMENT
Doctors find new non-surgical treatment for osteoarthritis patients that may relieve knee pain in weeksA groundbreaking minimally invasive procedure, knee embolization, is offering new hope for knee osteoarthritis sufferers. Developed by Colu...- Social media is abuzz with weight-loss drug retatrutide and longevity goals. What is the drug all about?A new weight-loss drug, retatrutide, is generating excitement. This investigational medicine targets three hormone receptors, offering a po...
- Struggling with knee pain? New study says the cure starts with movement, not rest: Try these exercises to ease pain within weeksNew research published in The BMJ and reported by Women’s Health reveals that movement, not rest, is the key to easing knee pain caused by ...
- Novo Nordisk to test weight-loss drugs in broader range of obesity-linked conditionsNovo Nordisk is broadening its focus beyond obesity and diabetes by exploring the potential of its weight-loss drugs, including Wegovy, to ...
- Study reveals a simple technique to ease knee arthritis pain, and it can be as effective as medication: What is gait retraining?A new study in The Lancet Rheumatology suggests gait retraining — making subtle changes to walking patterns — can ease knee osteoarthritis ...
- Arthritis pain relief without drugs or surgery, study suggestsArthritis, a disorder affecting nearly one in four adults over 40, remains a resulting source of constant pain and disability. Osteoarthrit...
- IIT Guwahati researchers develop tailored solutions based on regenerative therapies for knee meniscus tearsResearchers from the Indian Institute of Technology (IIT) Guwahati, in collaboration with the University of Animal and Fishery Sciences, Ko...
- What other health conditions might weight-loss drugs treat?New data suggests that semaglutide may also cut the risk of stroke or heart attack, and may delay the progression of kidney disease in diab...
- Painkiller Meftal could cause adverse reactions: IPCThe commission, in its alert, stated that a preliminary analysis of adverse drug reactions from the Pharmacovigilance Programme of India (P...
- Around 1 bn people globally will live with osteoarthritis by 2050, says Lancet studyA recent study published in The Lancet Rheumatology journal predicts that nearly one billion people worldwide will be living with osteoarth...
- One billion people globally to have osteoarthritis by 2050: Lancet StudyBy 2050, nearly one billion people globally are projected to be living with osteoarthritis, according to a study published in The Lancet Rh...
- Scientists develop model for better diagnosis, treatment of osteoarthritisThe paper builds on another recent study the RIT-Cornell team published in Soft Matter that looked at how cartilage's properties resisted f...
- Unichem Labs gets American drug regulator's nod to market generic Celecoxib capsulesThe company has received abbreviated new drug application (ANDA) approval for its Celecoxib capsules in the strengths of 50 mg, 100 mg, 200...
- Don't ignore joint pain with fever, fatigue: It can mean rheumatoid arthritisRheumatoid arthritis, an autoimmune disease, tends to affect women more than men.
- Unichem Labs gets USFDA nod for arthritis drugPiroxicam is a non-steroidal anti-inflammatory drug (NSAID) indicated for relief of the signs and symptoms of osteoarthritis (OA) and rheum...
- Stempeutics plans stem cell device launch in India by mid 2016The company is looking for a strategic partner to globalise and market this device in India and outside.
- Cipla's Stempeutics gets process patent for Stempeucel from JapanStempeutics has received process patent from the Japan for novel stem cell drug Stempeucel aimed at treatment of critical limb ischemia.
- Lupin launches generic version of Celebrex in US marketLupin had earlier signed a licensing agreement with Pfizer Inc for Celebrex, which has an annual sales of $ 2.54 billion in US market, it a...
- Cadila gets USFDA nod to market arthritis drug EtodolacCadila Healthcare today said it has received US health regulator's nod to market Etodolac extended release tablets, used in the treatment o...
- Lupin gets USFDA approval for arthritis tabletsLupin Pharmaceuticals Inc has been granted final approval by US Food and Drug Administration for Nabumetone tablets in strengths of 500mg a...
Load More
